be_ixf;ym_202512 d_08; ct_50

Latest Insights on ABBV

Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]
This Biotech Billionaire Loves This Risky Stock April 11, 2018 by Brian Christopher Technology, Trending There is a chance you will lose money if you buy today’s stock. But if you’re willing to take on a little risk, I have an opportunity for you that could be very profitable.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Looks like I have finally found the right person to learn and grow from.”

- James

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

Share This